<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32295914</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>13</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Early Entry Events in Echovirus 30 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00592-20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00592-20</ELocationID><Abstract><AbstractText>Echovirus 30 (E30), a member of the enterovirus B species, is a major cause of viral meningitis, targeting children and adults alike. While it is a frequently isolated enterovirus and the cause of several outbreaks all over the world, surprisingly little is known regarding its entry and replication strategy within cells. In this study, we used E30 strain Bastianni (E30B) generated from an infectious cDNA clone in order to study early entry events during infection in human RD cells. E30B required the newly discovered Fc echovirus receptor (FcRn) for successful infection, but not the coxsackievirus and adenovirus receptor (CAR) or decay-accelerating factor (DAF), although an interaction with DAF was observed. Double-stranded RNA replication intermediate was generated between 2 and 3 h postinfection (p.i.), and viral capsid production was initiated between 4 and 5 h p.i. The drugs affecting Rac1 (NSC 23766) and cholesterol (filipin III) compromised infection, whereas bafilomycin A1, dyngo, U-73122, wortmannin, and nocodazole did not, suggesting the virus follows an enterovirus-triggered macropinocytic pathway rather than the clathrin pathway. Colocalization with early endosomes and increased infection due to constitutively active Rab5 expression suggests some overlap and entry to classical early endosomes. Taken together, these results suggest that E30B induces an enterovirus entry pathway, leading to uncoating in early endosomes.<b>IMPORTANCE</b> Echovirus 30 (E30) is a prevalent enterovirus causing regular outbreaks in both children and adults in different parts of the world. It is therefore surprising that relatively little is known of its infectious entry pathway. We set out to generate a cDNA clone and gradient purified the virus in order to study the early entry events in human cells. We have recently studied other enterovirus B group viruses, like echovirus 1 (EV1) and coxsackievirus A9 (CVA9), and found many similarities between those viruses, allowing us to define a so-called "enterovirus entry pathway." Here, E30 is reminiscent of these viruses, for example, by not relying on acidification for infectious entry. However, despite not using the clathrin entry pathway, E30 accumulates in classical early endosomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vandesande</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laajala</LastName><ForeName>Mira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kantoluoto</LastName><ForeName>Tino</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruokolainen</LastName><ForeName>Visa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindberg</LastName><ForeName>A Michael</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marjom&#xe4;ki</LastName><ForeName>Varpu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland varpu.s.marjomaki@jyu.fi.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011961">Receptors, Fc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004457" MajorTopicYN="N">Echovirus Infections</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011961" MajorTopicYN="N">Receptors, Fc</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aseptic meningitis</Keyword><Keyword MajorTopicYN="N">early entry</Keyword><Keyword MajorTopicYN="N">echovirus 30</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32295914</ArticleId><ArticleId IdType="pmc">PMC7307138</ArticleId><ArticleId IdType="doi">10.1128/JVI.00592-20</ArticleId><ArticleId IdType="pii">JVI.00592-20</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Irani DN. 2008. Aseptic meningitis and viral myelitis. Neurol Clin 26:635&#x2013;655. doi:10.1016/j.ncl.2008.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2008.03.003</ArticleId><ArticleId IdType="pmc">PMC2728900</ArticleId><ArticleId IdType="pubmed">18657719</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Quiroz ES, Holman RC, Anderson LJ. 2003. Viral meningitis-associated hospitalizations in the United States, 1988&#x2013;1999. Neuroepidemiology 22:345&#x2013;352. doi:10.1159/000072924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000072924</ArticleId><ArticleId IdType="pubmed">14557685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch MA, Roos RP. 2007. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p 839&#x2013;893. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 1 Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Connolly KJ, Hammer SM. 1990. The acute aseptic meningitis syndrome. Infect Dis Clin North Am 4:599&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">2277191</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart HA. 2000. Viral meningitis. Semin Neurol 20:277&#x2013;292. doi:10.1055/s-2000-9427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2000-9427</ArticleId><ArticleId IdType="pubmed">11051293</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson KL, Ramsay ME. 2003. The epidemiology of acute meningitis in children in England and Wales. Arch Dis Child 88:662&#x2013;664. doi:10.1136/adc.88.8.662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.88.8.662</ArticleId><ArticleId IdType="pmc">PMC1719594</ArticleId><ArticleId IdType="pubmed">12876156</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan SA, MacMahon E. 2008. Viral meningitis. BMJ 336:36&#x2013;40. doi:10.1136/bmj.39409.673657.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39409.673657.AE</ArticleId><ArticleId IdType="pmc">PMC2174764</ArticleId><ArticleId IdType="pubmed">18174598</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita K, Miyamura K, Yamadera S, Kato N, Akatsuka M, Hashido M, Inouye S, Yamazaki S. 1994. Epidemics of aseptic meningitis due to echovirus 30 in Japan. A report of the National Epidemiological Surveillance of Infectious Agents in Japan. Jpn J Med Sci Biol 47:221&#x2013;239. doi:10.7883/yoken1952.47.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken1952.47.221</ArticleId><ArticleId IdType="pubmed">7715095</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Kennett ML, Campbell JJ, Carpenter MS, Schnurr D, Pallansch MA. 1999. Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol 37:3928&#x2013;3933. doi:10.1128/JCM.37.12.3928-3933.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.12.3928-3933.1999</ArticleId><ArticleId IdType="pmc">PMC85848</ArticleId><ArticleId IdType="pubmed">10565909</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoelen I, Lemey P, Van Der Donck I, Beuselinck K, Lindberg AM, Van Ranst M. 2003. Molecular typing and epidemiology of enteroviruses identified from an outbreak of aseptic meningitis in Belgium during the summer of 2000. J Med Virol 70:420&#x2013;429. doi:10.1002/jmv.10412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10412</ArticleId><ArticleId IdType="pubmed">12767006</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. 2003. Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity&#x2014;United States, 2003. MMWR Morb Mortal Wkly Rep 52:761&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pubmed">12917581</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). 2006. Enterovirus surveillance&#x2014;United States, 2002&#x2013;2004. MMWR Morb Mortal Wkly Rep 55:153&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484979</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliam Leitch EC, Bendig J, Cabrerizo M, Cardosa J, Hyypi&#xe4; T, Ivanova OE, Kelly A, Kroes AC, Lukashev A, MacAdam A, McMinn P, Roivainen M, Trallero G, Evans DJ, Simmonds P. 2009. Transmission networks and population turnover of echovirus 30. J Virol 83:2109&#x2013;2118. doi:10.1128/JVI.02109-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02109-08</ArticleId><ArticleId IdType="pmc">PMC2643716</ArticleId><ArticleId IdType="pubmed">19091869</ArticleId></ArticleIdList></Reference><Reference><Citation>Broberg EK, Simone B, Jansa J, EU/EEA Member State Contributors. 2018. Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018. Euro Surveill 23:1800537. doi:10.2807/1560-7917.ES.2018.23.44.1800537.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.44.1800537</ArticleId><ArticleId IdType="pmc">PMC6337069</ArticleId><ArticleId IdType="pubmed">30401013</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. 1999. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73:1941&#x2013;1948. doi:10.1128/JVI.73.3.1941-1948.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.3.1941-1948.1999</ArticleId><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrich S, Driesel G, Schreier E. 1995. Sequence comparison of echovirus type 30 isolates to other enteroviruses in the 5&#x2032; noncoding region. J Med Virol 46:148&#x2013;152. doi:10.1002/jmv.1890460212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890460212</ArticleId><ArticleId IdType="pubmed">7636503</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttunen M, Waris M, Kajander R, Hyypi&#xe4; T, Marjom&#xe4;ki V. 2014. Coxsackievirus A9 infects cells via nonacidic multivesicular bodies. J Virol 88:5138&#x2013;5151. doi:10.1128/JVI.03275-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03275-13</ArticleId><ArticleId IdType="pmc">PMC3993817</ArticleId><ArticleId IdType="pubmed">24574401</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieti&#xe4;inen V, Marjom&#xe4;ki V, Upla P, Pelkmans L, Helenius A, Hyypi&#xe4; T. 2004. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 15:4911&#x2013;4925. doi:10.1091/mbc.e04-01-0070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-01-0070</ArticleId><ArticleId IdType="pmc">PMC524743</ArticleId><ArticleId IdType="pubmed">15356270</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320&#x2013;1323. doi:10.1126/science.275.5304.1320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.275.5304.1320</ArticleId><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP. 2000. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271:99&#x2013;108. doi:10.1006/viro.2000.0324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0324</ArticleId><ArticleId IdType="pubmed">10814575</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjom&#xe4;ki V, Turkki P, Huttunen M. 2015. Infectious entry pathway of enterovirus B species. Viruses 7:6387&#x2013;6399. doi:10.3390/v7122945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122945</ArticleId><ArticleId IdType="pmc">PMC4690868</ArticleId><ArticleId IdType="pubmed">26690201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A 91:6245&#x2013;6248. doi:10.1073/pnas.91.13.6245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.13.6245</ArticleId><ArticleId IdType="pmc">PMC44175</ArticleId><ArticleId IdType="pubmed">7517044</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69:3873&#x2013;3877. doi:10.1128/JVI.69.6.3873-3877.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.6.3873-3877.1995</ArticleId><ArticleId IdType="pmc">PMC189108</ArticleId><ArticleId IdType="pubmed">7538177</ArticleId></ArticleIdList></Reference><Reference><Citation>Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM. 2005. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 79:655&#x2013;660. doi:10.1128/JVI.79.1.655-660.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.1.655-660.2005</ArticleId><ArticleId IdType="pmc">PMC538729</ArticleId><ArticleId IdType="pubmed">15596863</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell RM, Schmitt V, Ward T, Goodfellow I, Evans DJ, Almond JW. 1998. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 79:1707&#x2013;1713. doi:10.1099/0022-1317-79-7-1707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-79-7-1707</ArticleId><ArticleId IdType="pubmed">9680134</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothe D, Werk D, Niedrig S, Horbelt D, Grunert HP, Zeichhardt H, Erdmann VA, Kurreck J. 2009. Antiviral activity of highly potent siRNAs against echovirus 30 and its receptor. J Virol Methods 157:211&#x2013;218. doi:10.1016/j.jviromet.2009.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2009.01.012</ArticleId><ArticleId IdType="pubmed">19187792</ArticleId></ArticleIdList></Reference><Reference><Citation>Morosky S, Wells AI, Lemon K, Evans AS, Schamus S, Bakkenist CJ, Coyne CB. 2019. The neonatal Fc receptor is a pan-echovirus receptor. Proc Natl Acad Sci U S A 116:3758&#x2013;3763. doi:10.1073/pnas.1817341116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1817341116</ArticleId><ArticleId IdType="pmc">PMC6397586</ArticleId><ArticleId IdType="pubmed">30808762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Zhang G, Liu S, Chen X, Peng R, Dai L, Qu X, Li S, Song H, Gao Z, Yuan P, Liu Z, Li C, Shang Z, Li Y, Zhang M, Qi J, Wang H, Du N, Wu Y, Bi Y, Gao S, Shi Y, Yan J, Zhang Y, Xie Z, Wei W, Gao GF. 2019. Human neonatal Fc receptor is the cellular uncoating receptor for enterovirus B. Cell 177:1553&#x2013;1565. doi:10.1016/j.cell.2019.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.04.035</ArticleId><ArticleId IdType="pmc">PMC7111318</ArticleId><ArticleId IdType="pubmed">31104841</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K, Triantafilou M. 2004. Lipid-raft-dependent coxsackievirus B4 internalization and rapid targeting to the Golgi. Virology 326:6&#x2013;19. doi:10.1016/j.virol.2004.04.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2004.04.051</ArticleId><ArticleId IdType="pubmed">15262490</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KP, Coyne CB, Bergelson JM. 2009. Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. J Virol 83:11064&#x2013;11077. doi:10.1128/JVI.01016-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01016-09</ArticleId><ArticleId IdType="pmc">PMC2772800</ArticleId><ArticleId IdType="pubmed">19710132</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger SE, Kim C, Zhang L, Marjomaki V, Bergelson JM. 2013. Echovirus 1 entry into polarized Caco-2 cells depends on dynamin, cholesterol, and cellular factors associated with macropinocytosis. J Virol 87:8884&#x2013;8895. doi:10.1128/JVI.03415-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03415-12</ArticleId><ArticleId IdType="pmc">PMC3754084</ArticleId><ArticleId IdType="pubmed">23740983</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjom&#xe4;ki V, Pieti&#xe4;inen V, Matilainen H, Upla P, Ivaska J, Nissinen L, Reunanen H, Huttunen P, Hyypi&#xe4; T, Heino J. 2002. Internalization of echovirus 1 in caveolae. J Virol 76:1856&#x2013;1865. doi:10.1128/jvi.76.4.1856-1865.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.4.1856-1865.2002</ArticleId><ArticleId IdType="pmc">PMC135881</ArticleId><ArticleId IdType="pubmed">11799180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M. 1992. The small GTPase Rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70:715&#x2013;728. doi:10.1016/0092-8674(92)90306-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90306-w</ArticleId><ArticleId IdType="pubmed">1516130</ArticleId></ArticleIdList></Reference><Reference><Citation>Feliciano WD, Yoshida S, Straight SW, Swanson JA. 2011. Coordination of the Rab5 cycle on macropinosomes. Traffic 12:1911&#x2013;1922. doi:10.1111/j.1600-0854.2011.01280.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2011.01280.x</ArticleId><ArticleId IdType="pmc">PMC3213305</ArticleId><ArticleId IdType="pubmed">21910808</ArticleId></ArticleIdList></Reference><Reference><Citation>Egami Y, Taguchi T, Maekawa M, Arai H, Araki N. 2014. Small GTPases and phosphoinositides in the regulatory mechanisms of macropinosome formation and maturation. Front Physiol 5:374. doi:10.3389/fphys.2014.00374.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00374</ArticleId><ArticleId IdType="pmc">PMC4179697</ArticleId><ArticleId IdType="pubmed">25324782</ArticleId></ArticleIdList></Reference><Reference><Citation>Selinka HC, Wolde A, Pasch A, Klingel K, Schnorr JJ, K&#xfc;pper JH, Lindberg AM, Kandolf R. 2002. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis. J Med Virol 67:224&#x2013;233. doi:10.1002/jmv.2211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2211</ArticleId><ArticleId IdType="pubmed">11992583</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelsson S, S&#xe4;vneby A, Ekstr&#xf6;m JO, Jonsson N, Edman K, Lindberg AM. 2014. Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5&#x2032; RNA genome end methodology. Invest New Drugs 32:1063&#x2013;1070. doi:10.1007/s10637-014-0136-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-014-0136-z</ArticleId><ArticleId IdType="pubmed">25052234</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham G, Colonno RJ. 1984. Many rhinovirus serotypes share the same cellular receptor. J Virol 51:340&#x2013;345. doi:10.1128/JVI.51.2.340-345.1984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.51.2.340-345.1984</ArticleId><ArticleId IdType="pmc">PMC254443</ArticleId><ArticleId IdType="pubmed">6086949</ArticleId></ArticleIdList></Reference><Reference><Citation>Myllynen M, Kazmertsuk A, Marjom&#xe4;ki V. 2016. A novel open and infectious form of echovirus 1. J Virol 90:6759&#x2013;6770. doi:10.1128/JVI.00342-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00342-16</ArticleId><ArticleId IdType="pmc">PMC4944302</ArticleId><ArticleId IdType="pubmed">27194757</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkki P, Laajala M, Stark M, Vandesande H, Sallinen-Dal Maso H, Shroff S, S&#xe4;vneby A, Galitska G, Lindberg AM, Marjom&#xe4;ki V. 2019. Slow infection due to lowering the amount of intact versus empty particles is a characteristic feature of coxsackievirus B5 dictated by the structural proteins. J Virol 93:e01130-19. doi:10.1128/JVI.01130-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01130-19</ArticleId><ArticleId IdType="pmc">PMC6798118</ArticleId><ArticleId IdType="pubmed">31375587</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676&#x2013;682. doi:10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Manders EMM, Verbeek FJ, Aten JA. 1993. Measurement of co&#x2010;localization of objects in dual&#x2010;colour confocal images. J Microsc 169:375&#x2013;382. doi:10.1111/j.1365-2818.1993.tb03313.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.1993.tb03313.x</ArticleId><ArticleId IdType="pubmed">33930978</ArticleId></ArticleIdList></Reference><Reference><Citation>Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S. 2004. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 86:3993&#x2013;4003. doi:10.1529/biophysj.103.038422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.103.038422</ArticleId><ArticleId IdType="pmc">PMC1304300</ArticleId><ArticleId IdType="pubmed">15189895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>